Ongoing Clinical Trials As of December 2024, over 30 active clinical trials are investigating nanomedicine-based RA therapies, spanning phase I-IV and observational studies (54)
Cho YY, Kang MJ, Kim SK, Jung JH, Hahm JR, Kim TH, et al
SUSTAIN 2 was a 56-week, randomized, double-blinded trial comparing semaglutide 0.5 mg and 1 mg with once-daily sitagliptin 100 mg in people with type 2 diabetes uncontrolled on metformin, pioglitazone, rosiglitazone, or combinations of either metformin and pioglitazone or metformin and rosiglitazone [18]
However, the same group reported decreased QA-immunoreactive microglia in the hippocampus, suggesting that QA expression in the brain may be region-specific or that hippocampal cell atrophy may have hindered its detection [63]
A blood test can show if you are low on B12